Ecolab Launches Hard-Surface Disinfectant Effective Against C. difficile
Ecolab Inc. announces the launch of Virasept, Ecolabs first ready-to-use (no mixing required) hard-surface disinfectant approved by the Environmental Protection Agency (EPA) to be effective against Clostridium difficile spores.
Ecolab Inc. announces the launch of Virasept, Ecolabs first ready-to-use (no mixing required) hard-surface disinfectant approved by the Environmental Protection Agency (EPA)Â to be effective against Clostridium difficile spores.
Â
Developing effective methods to clean rooms contaminated with Clostridium difficile is particularly challenging due to the persistence of the spore in the environment. Virasept is an effective, non-bleach alternative that can help reduce the environmental transmission of challenging microorganisms like Clostridium difficile.
Â
Clostridium difficile is a highly drug-resistant bacterium that causes diarrhea and severe lower intestinal inflammation, which can be life-threatening. It is very difficult to clean and can remain on hard surfaces for months. Over the past few years the incidence of Clostridium difficile has been on the rise in healthcare settings with studies showing it affecting more than 7,000 patients in hospitals each day with an estimated cost of $18 million to $52 million.
Â
Environmental services departments continue to face increasingly more virulent and persistent pathogens as they work to keep healthcare facilities clean, said Paul B. Chaffin, vice president of Ecolab Healthcare North America. Developing effective methods to clean rooms contaminated with Clostridium difficile is particularly challenging due to the persistence of the spore in the environment. Virasept is an effective, non-bleach alternative that can help reduce the environmental transmission of challenging microorganisms like Clostridium difficile.
Â
Virasept is designed to work within 10 minutes of application against Clostridium difficile spores and in four minutes or less for a broad spectrum of other pathogens, including MRSA, VRE, E. coli, HIV, hepatitis B, Influenza A (H1N1), and Norovirus. Its patented, non-corrosive chemistry is formulated for daily cleaning of high-touch room surfaces such as hand rails, telephones, bathroom fixtures, sinks and tray tables without harming the equipment. Virasept cleans, disinfects and deodorizes in one-step, helping to reduce the need for inventory of multiple products.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.
